[ad_1]
While overall healthcare funding saw a marginal increase, healthtech startups struggled, with many tech-led pandemic darlings failing to scale post-Covid. Investors now prioritise businesses with tangible patient outcomes and strong unit economics.
[ad_2]
Source link
